
|Articles|September 20, 2019
Challenges and Barriers to 503B Compounding
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Advertisement
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
2
Understanding the Criteria, Process for Rx-to-OTC Switches
3
Extreme Weather Disrupts Pharmacy Operations and Community Health Resilience
4
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
5


















